Exec Chat: Cumulus Neuroscience Help Trials Collect Previously Underutilized, Vital Data
Executive Summary
Cumulus Neuroscience, previously known as BrainWaveBank, announced a £6m financing round to help develop its unique neurological data collection system.
You may also be interested in...
Digital Health Roundup, April 2021: Digital Transformation In OR, Clinical Trials, Remote Monitoring
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from April.
Data Gathering Devices Offer Big Potential In Neurological Drug Trials
As wearable technologies and other devices become capable of recording large amounts of data for use in clinical trials, industry experts are asking why pharma has been slow to maximize the opportunity in product development.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.